12
Ehlers-Danlos syndromes and Marfan syndrome

https://doi.org/10.1016/j.berh.2007.12.005Get rights and content

Ehlers-Danlos syndromes (EDS) and Marfan syndrome (MFS) are multisystemic disorders that primarily affect the soft connective tissues. Both disorders have benefited from recent advances in clinical and molecular characterization, allowing improvements in clinical diagnosis and management. EDS are a heterogeneous group of conditions characterized by skin hyperextensibility, atrophic scarring, joint hypermobility and generalized tissue fragility. The current classification proposes six subtypes based on clinical, biochemical and molecular characteristics. However, examples of unclassified variants and ‘overlap phenotypes’ are becoming more common. Mutations in genes encoding fibrillar collagens or collagen-modifying enzymes have been identified in most forms of EDS, including the classic and vascular subtypes (collagen type V and III, respectively), and the rare arthrochalasis, kyphoscoliosis and dermatosparaxis variants (type I collagen defects). To date, the genetic background of the hypermobility type of EDS remains unclear, although some new insights have been gained recently.

MFS is an autosomal-dominant disorder that affects the cardiovascular, ocular and skeletal system with aortic root dilation/dissection, ectopia lentis and bone overgrowth, respectively. Advances in therapeutic, mainly surgical, techniques have improved median survival significantly, yet severe morbidity and a substantial risk for premature mortality remain associated. The disorder is caused by mutations in the FBN1 gene, encoding the microfibrillar protein fibrillin-1. Recently, new insights in the pathogenesis changed the prevailing concept of this type 1 fibrillinopathy as a structural disorder of the connective tissue into a developmental abnormality manifesting perturbed cytokine signalling. These findings have opened new and unexpected targets for aetiologically directed drug treatments.

Section snippets

Acknowledgements

The authors are indebted to Paul Coucke and Sofie Symoens for supervision of the molecular and biochemical analyses, and to Petra Van Acker and Karen Wettinck for technical assistance. This work is supported by Grant G.0171.05 and Grant G.0094.06 from the fund for Scientific Research-Flanders (to ADP), a GOA Research Grant from the Ghent University (to ADP) and by the Geneskin Consortium within the Sixth Framework Programme of the European Commission.

References (80)

  • U. Takeda et al.

    Targeted disruption of dermatopontin causes abnormal collagen fibrillogenesis

    Journal of Investigative Dermatology

    (2002)
  • E. Rodahl et al.

    A second decorin frame shift mutation in a family with congenital stromal corneal dystrophy

    American Journal of Ophthalmology

    (2006)
  • D.F. Cikrit et al.

    Spontaneous arterial perforation: the Ehlers-Danlos specter

    Journal of Vascular Surgery

    (1987)
  • M.J. Roman et al.

    Two-dimensional echocardiographic aortic root dimensions in normal children and adults

    American Journal of Cardiology

    (1989)
  • D.I. Silverman et al.

    Life expectancy in the Marfan syndrome

    American Journal of Cardiology

    (1995)
  • J. De Backer et al.

    A critical analysis of minor cardiovascular criteria in the diagnostic evaluation of patients with Marfan syndrome

    Genetics in Medicine

    (2006)
  • R.E. Pyeritz et al.

    Mitral valve dysfunction in the Marfan syndrome. Clinical and echocardiographic study of prevalence and natural history

    American Journal of Medicine

    (1983)
  • H.E. Sisk et al.

    The Marfan syndrome in early childhood: analysis of 15 patients diagnosed at less than 4 years of age

    American Journal of Cardiology

    (1983)
  • J.F. De Backer et al.

    Primary impairment of left ventricular function in Marfan syndrome

    International Journal of Cardiology

    (2006)
  • R. Fattori et al.

    Importance of dural ectasia in phenotypic assessment of Marfan's syndrome

    Lancet

    (1999)
  • E.A. Streeten et al.

    Pulmonary function in the Marfan syndrome

    Chest

    (1987)
  • A. Biddinger et al.

    Familial thoracic aortic dilatations and dissections: a case control study

    Journal of Vascular Surgery

    (1997)
  • A.C. Braverman et al.

    The bicuspid aortic valve

    Current Problems in Cardiology

    (2005)
  • N. Dagoneau et al.

    ADAMTS10 mutations in autosomal recessive Weill-Marchesani syndrome

    American Journal of Human Genetics

    (2004)
  • R.A. Montgomery et al.

    Multiple molecular mechanisms underlying subdiagnostic variants of Marfan syndrome

    American Journal of Human Genetics

    (1998)
  • F.L. Raymond et al.

    Mutations in ZDHHC9, which encodes a palmitoyltransferase of NRAS and HRAS, cause X-linked mental retardation associated with a Marfanoid habitus

    American Journal of Human Genetics

    (2007)
  • L. Ades

    Guidelines for the diagnosis and management of Marfan syndrome

    Heart, Lung and Circulation

    (2007)
  • K. Kallenbach et al.

    Aortic valve-sparing operation in Marfan syndrome: what do we know after a decade?

    Annals of Thoracic Surgery

    (2007)
  • M.L. Lawson et al.

    Impact of pectus excavatum on pulmonary function before and after repair with the Nuss procedure

    Journal of Pediatric Surgery

    (2005)
  • B. Steinmann et al.

    The Ehlers-Danlos syndrome

  • P. Beighton et al.

    International nosology of heritable disorders of connective tissue, Berlin, 1986

    American Journal of Medical Genetics

    (1988)
  • P. Beighton et al.

    Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK)

    American Journal of Medical Genetics

    (1998)
  • B.L. Loeys et al.

    Aneurysm syndromes caused by mutations in the TGF-beta receptor

    New England Journal of Medicine

    (2006)
  • S.G. Kaler et al.

    Occipital horn syndrome and a mild Menkes phenotype associated with splice site mutations at the MNK locus

    Nature Genetics

    (1994)
  • E. Mercuri et al.

    Congenital muscular dystrophy with short stature, proximal contractures and distal laxity

    Neuropediatrics

    (2004)
  • O. Camacho Vanegas et al.

    Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI

    Proceedings of the National Academy of Sciences of the United States of America

    (2001)
  • N.L. Baker et al.

    Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy

    Human Molecular Genetics

    (2005)
  • F. Malfait et al.

    The molecular basis of classic Ehlers-Danlos syndrome: a comprehensive study of biochemical and molecular findings in 48 unrelated patients

    Human Mutation

    (2005)
  • J. Schalkwijk et al.

    A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency

    New England Journal of Medicine

    (2001)
  • R.J. Wenstrup et al.

    A splice-junction mutation in the region of COL5A1 that codes for the carboxyl propeptide of pro alpha 1(V) chains results in the gravis form of the Ehlers-Danlos syndrome (type I)

    Human Molecular Genetics

    (1996)
  • Cited by (197)

    • EMILIN1 deficiency causes arterial tortuosity with osteopenia and connects impaired elastogenesis with defective collagen fibrillogenesis

      2022, American Journal of Human Genetics
      Citation Excerpt :

      Our work identifies EMILIN1 as a link between elastin and collagen networks, positioning LOX function centrally in the pathogenesis of elastinopathies. This can be relevant for other monogenic disorders of the soft connective tissues, including Marfan syndrome (MIM: 154700),42 several types of EDS,43 congenital contractural arachnodactyly (MIM: 121050),44 and cutis laxa25,38 that also present with osteopenia and bone overgrowth phenotypes. Moreover, it provides an additional mechanism for variability in age-related fracture risks as reduced skin elasticity has been observed in a population with more pronounced osteopenia.45

    • Ehlers-Danlos Syndrome: Immunologic contrasts and connective tissue comparisons

      2021, Journal of Translational Autoimmunity
      Citation Excerpt :

      These diseases can be associated with chronic pain and take a toll on the psychosocial aspect of patients. Therefore, through the use of proper diagnostic measures and evaluation, it is important to rule out EDS to ensure that suspected patients are given appropriate care accordingly [11,37,38]. Other conditions including Menkes syndrome, familial aortic aneurysms, and pseudoxanthoma elasticum can also be confused with EDS and must be differentiated.

    View all citing articles on Scopus
    View full text